I am pleased to introduce you to the Department of Molecular and Human Genetics at Baylor College of Medicine. We strive to transform medicine with the practice and science of genetics and genomics. The integrated research, clinical, and diagnostic activities housed within our department have led in the transformation of genetic medicine. In spite of the challenges of the COVID19 pandemic, our team continues to excel in all aspects of our mission.
We continue to be a top-ranked genetics department. Among other U.S. genetics departments, our department has consistently ranked first in total awarded NIH funding and total number of NIH grants.
We continue to be leaders in the diagnostic testing arena with our joint venture with H.U. Group Holdings, Inc., Baylor Genetics. This jointly governed laboratory continues to support the academic mission and innovation of the department while promising to extend the impact of genetic diagnostic testing world-wide including, most recently, for infectious diseases.
On the clinical front, in 2016, we established the Baylor College of Medicine & Chinese University of Hong Kong Center for Medical Genetics where our faculty is delivering the department's clinical, training, and research missions to a global venue.
Since then, we led the development of a new masters in genetic counseling program and in 2018, it's inaugural class began their studies. Also in 2018, we launched a new web-based platform called Consultagene, with the aim of expanding the department’s comprehensive genetic services and providing patient education, genetic counseling, peer-to-peer medical consultations in a virtual setting.
In addition, new and continuing consortia with the National Institutes of Health and industry are leading to new gene discoveries and advancements in the implementation of genetics and genomics. These consortia include the All of Us program, the Undiagnosed Diseases Network, the Centers for Mendelian Genomics, the Knockout Mouse Phenotyping Program, the Center for Precision Medicine Models, Clinical Genome Resource, Clinical Sequencing Evidence-Generating Research, and the Rare Diseases Clinical Research Network.
Ultimately, the innovation that has characterized our department continues to reside in our two greatest assets: our renowned faculty and trainees.
Brendan Lee, M.D., Ph.D.
Robert and Janice McNair Endowed Chair in Molecular and Human Genetics